Penumbra, Inc. $PEN Holdings Decreased by Hantz Financial Services Inc.

Hantz Financial Services Inc. trimmed its position in Penumbra, Inc. (NYSE:PEN) by 9.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 44,780 shares of the company’s stock after selling 4,774 shares during the quarter. Hantz Financial Services Inc.’s holdings in Penumbra were worth $11,492,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Synergy Investment Management LLC bought a new stake in shares of Penumbra in the 1st quarter valued at approximately $27,000. First Horizon Advisors Inc. increased its holdings in shares of Penumbra by 404.8% in the 1st quarter. First Horizon Advisors Inc. now owns 106 shares of the company’s stock valued at $28,000 after acquiring an additional 85 shares during the last quarter. AlphaQuest LLC bought a new stake in shares of Penumbra in the 1st quarter valued at approximately $66,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Penumbra in the 1st quarter valued at approximately $76,000. Finally, Meeder Asset Management Inc. increased its holdings in shares of Penumbra by 1,966.7% in the 1st quarter. Meeder Asset Management Inc. now owns 372 shares of the company’s stock valued at $99,000 after acquiring an additional 354 shares during the last quarter. 88.88% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

PEN has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Penumbra in a report on Wednesday, October 8th. UBS Group set a $335.00 price objective on Penumbra and gave the company a “buy” rating in a research report on Wednesday, July 30th. Citigroup reduced their price objective on Penumbra from $320.00 to $285.00 and set a “neutral” rating for the company in a research report on Wednesday, July 9th. Robert W. Baird boosted their price objective on Penumbra from $283.00 to $285.00 and gave the company an “outperform” rating in a research report on Wednesday, July 30th. Finally, Truist Financial reduced their price objective on Penumbra from $310.00 to $300.00 and set a “buy” rating for the company in a research report on Wednesday, October 15th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $305.94.

Penumbra Trading Down 1.0%

Shares of PEN stock opened at $233.18 on Thursday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 4.04 and a current ratio of 6.75. Penumbra, Inc. has a 1 year low of $207.58 and a 1 year high of $310.00. The stock has a fifty day moving average of $259.61 and a two-hundred day moving average of $260.21. The firm has a market capitalization of $9.09 billion, a PE ratio of 62.02, a price-to-earnings-growth ratio of 2.12 and a beta of 0.41.

Penumbra (NYSE:PEN) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.05. The business had revenue of $339.46 million during the quarter, compared to analyst estimates of $327.37 million. Penumbra had a return on equity of 11.55% and a net margin of 11.54%.The company’s revenue was up 13.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.64 earnings per share. As a group, research analysts expect that Penumbra, Inc. will post 3.67 EPS for the current year.

Insiders Place Their Bets

In other news, Director Arani Bose sold 12,000 shares of the company’s stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $250.65, for a total value of $3,007,800.00. Following the completion of the sale, the director owned 558 shares in the company, valued at $139,862.70. This represents a 95.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Johanna Roberts sold 600 shares of the company’s stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $249.70, for a total value of $149,820.00. Following the completion of the sale, the executive vice president owned 64,257 shares of the company’s stock, valued at approximately $16,044,972.90. This trade represents a 0.93% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 64,460 shares of company stock valued at $16,322,614. 4.20% of the stock is currently owned by insiders.

Penumbra Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.